DKSH partners with Cytek Biosciences to strengthen presence in Asia

February 28, 2022 | 14:28

(0) user say

DKSH Business Unit Technology has entered an agreement with Cytek Biosciences in Asia in a move to solidify its position as a leading integrated solutions provider for scientific instruments.

DKSH partners with Cytek Biosciences to strengthen presence in Asia

DKSH will provide marketing, sales, and after-sales services in Indonesia, Malaysia, the Philippines, Thailand, and Vietnam.

Cytek Biosciences is a leading manufacturer of flow cytometry products on a mission to advance cancer and cell biology research.

Cytek’s solutions enable scientists to obtain deep biological insights rapidly and efficiently through high-quality, high-parametric datasets. Its powerful cell analysis technique and full spectrum flow cytometry help deliver deep immune cell profiling benefits to scientists in various fields, such as pharmaceutical companies and academic research institutions.

Full-spectrum flow cytometry can be widely applied in research areas, including in drug discovery, genomics, immune profiling, diagnostics, research, and inflammatory diseases.

Marco Farina, senior director of Business Development at DKSH said, “With the partnership with Cytek Biosciences, DKSH is able to expand its life sciences portfolio and accelerate growth for the business.”

Farina added, “We are excited to introduce Cytek Biosciences’ leading solutions to our customers and are confident to grow the market, leveraging our good sales coverage, strong application support, and excellence in after-sales services.”

By Bich Thuy

What the stars mean:

★ Poor ★ ★ Promising ★★★ Good ★★★★ Very good ★★★★★ Exceptional